5 Questions
What is the primary goal of optimizing medicines?
To ensure a person is taking their medicines as intended
What is the main purpose of the STOPP/START criteria?
To identify potential prescribing omissions in older people
What is the significance of the expansion of the STOPP/START criteria from version 2 to version 3?
It reflects an expansion of the pharmacopeia and clinical trials evidence base
What is the main difference between STOPP/START version 2 and version 3?
Version 3 has more criteria than version 2
What is the target population for the STOPP/START criteria?
Older people with multimorbidity and polypharmacy
Study Notes
Optimizing Medicines
- Optimizing medicines is crucial to ensure a person takes their medicines as intended, which can support the management of long-term conditions, multimorbidity, and polypharmacy.
STOPP/START Criteria
- The goal is to update and validate STOPP/START criteria for potentially inappropriate prescribing.
STOPP/START Version 3
- STOPP/START version 3 has been expanded and validated by an international European panel of experts in geriatric pharmacotherapy.
- Version 3 includes 190 criteria, significantly larger than version 2 (114 criteria).
- The expansion reflects the growth of the pharmacopeia and clinical trials evidence base relevant to older people since the publication of version 2.
Purpose of STOPP/START Version 3
- STOPP/START version 3 represents an updated explicit list of potentially inappropriate medications and potential prescribing omissions.
- The purpose is to optimize medication and minimize adverse drug reactions and events during medication review in older people, particularly those with multimorbidity and polypharmacy.
Update and validation of STOPP/START criteria for optimizing medicines, particularly for geriatric patients with long-term conditions, multimorbidity, and polypharmacy.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
